K811367

Substantially Equivalent

KALLESTAD ANTISERA TO PHENOBARBITAL

Applicant: Kallestad Laboratories, Inc.
Product code: DLZ
Advisory panel: Clinical Toxicology
Date received: 1981-05-14
Decision date: 1981-05-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.